second cancer

second cancer

Oncology A 1º CA that is either a new CA in a different organ in a Pt with a Hx of a first CA or a new CA linked to prior cancer therapy. See Occult cancer.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Grunewald continued to train and race despite her cancer diagnosis that saw her have several treatments to rid her of the illness, including having half of her liver removed in 2016.After having radiotherapy during her second cancer treatment in 2011, she finished fourth in the US 1500m trials for the 2012 London Olympics, missing out on a place in the team by one position.Grunewald, who often trained with her husband on the banks of the Mississippi River in Minneapolis, thought she was cancer free in 2016 - but within two years, scans showed she needed further treatment.
Summary: Data shows that common inherited factors, treatment can influence risk of second cancer
According to the company, this represents the second cancer project to emerge from its in-house discovery efforts in oncology.
Current tamoxifen users had a 66 percent lower risk for a second cancer after four years, compared with women who did not take tamoxifen.
An increasing number of cancer survivors develop a second cancer in a different tissue or location years after successful treatment.
This is the second Cancer Patient Experience Survey carried out by the Welsh Government and Macmillan Cancer Support.
Editor's Note: "People who are cured of head and neck cancer are still at very high risk for a second cancer in their mouth or throat, and, unfortunately, these second cancers are commonly fatal," noted Dr.
Ten years after his treatment he was then diagnosed with Non Hodgkin's Lymphoma and after the chemotherapy failed he sadly died he had only survived for 10 months after this second cancer which was unrelated to prostate cancer.
These survivors have an 18%-30% risk of developing a second cancer. Most of these second cancers are hormonally mediated, such as ovarian and uterine cancers, but there are some studies that indicate thyroid cancer is also increased."
Patients who died within 30 days of urothelial cancer diagnosis and patients who were diagnosed with a second cancer within 30 days were excluded from analysis to mitigate an ascertainment bias.
In the Lancet last year, a study of cancer patients treated five or more years earlier found 8% developed a second cancer years later related to radiation treatment of the first cancer, mainly breast and prostate cancers.